phase readout
saveNCT02917993: An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer
COMPLETEDupdated 2d ago
community read0 votes
Sponsor: Incyte Corporation. Phase: PHASE1. Conditions: Lung Cancer
view source ↗
comments(0)
5-min edit window · permanent after that